China’s stealth military device, Singapore’s grant for Taylor Swift, Hong Kong talent scheme earners: SCMP’s 7 highlights of the week
- From Hong Kong talent scheme entrants earning HK$50,000 a month to how statins can lower the risk of dementia, here are a few highlights from SCMP’s recent reporting
1. Chinese plasma stealth device set to make planes vanish from enemy radar
A team of scientists and engineers in China claim to have developed a new-generation plasma stealth device that can make almost any military aircraft vanish from a radar screen.
2. Professionals recruited under Hong Kong talent scheme earning HK$50,000 a month
The median monthly income of professionals recruited under Hong Kong’s leading talent admission scheme is HK$50,000 (US$6,390), more than double what locals are earning, the city’s leader has revealed.
3. ‘Smart’ move: Singapore’s grant for Taylor Swift earns praise and brickbats
Singapore’s decision to pay American pop star Taylor Swift a grant to perform in the city state allegedly on an exclusivity clause has divided online users.
4. As China powers ahead on EVs, battery plant health risks raise a red flag
China’s electric car market is No 1 in the world but factory findings by health authorities around the country have now shed light on the lesser-known health impact of the rapidly developing industry.
5. Dark history of Malaysia’s Chinese villages underscores fury over Unesco bid
A proposal by the Malaysian government to seek Unesco heritage status for a cluster of “New Villages” in Selangor has sparked heated debate between the Malay and Chinese communities over whose culture is pre-eminent in a country where historical racial wounds are still festering.
6. ‘Hong Kong employer of late Filipino helper asked to pay HK$580,000 for damages’
A Hong Kong employer has been sued for damages and is asked to pay more than HK$580,000 (US$74,155) in compensation for depriving her late Filipino domestic helper of food and firing her after her cancer diagnosis, a court has heard.
7. How statins, used to lower cholesterol, could also lower risk of dementia
Recent research suggests a drug more than 200 million people worldwide take for their heart health might prevent dementia, or delay its progress.
